Blog
Running Shoes vs Walking Shoes: Key Differences & Which Is Right for You
Most people pick up a pair of shoes based on what looks good or what is on sale and wear them for everything. Walking
Medically Reviewed by
Dr. Peter Hanna, DPM
Board Certified Podiatrist
By the time most people reach their 30s, the body’s natural production of human growth hormone (HGH) begins to decline, quietly, gradually, and consequentially. Energy dips. Body fat accumulates around the midsection. Sleep becomes lighter and less restorative. For many health-conscious adults in Miami and across South Florida, Sermorelin therapy has emerged as a compelling, physiologically sound answer to these shifts.
Sermorelin is a synthetic peptide that mimics Growth Hormone-Releasing Hormone (GHRH), the signal your hypothalamus sends to your pituitary gland to produce HGH. Unlike synthetic HGH injections, Sermorelin does not introduce exogenous hormones into your system. Instead, it works with your body’s existing biology, prompting the pituitary gland to release more of its own natural growth hormone. This distinction is not just semantic; it shapes the entire safety and efficacy profile of the therapy.
At South Florida Multispecialty Medical Group (SFL Medical Group), we offer Sermorelin therapy as part of a broader hormone optimization program, designed for adults who want to address the root cause of age-related hormonal decline rather than simply masking the symptoms.
To understand why Sermorelin is so effective, we need to look at how the body regulates growth hormone in the first place.
The hypothalamus produces GHRH, which travels to the pituitary gland and triggers the release of HGH into the bloodstream. HGH then signals the liver to produce Insulin-like Growth Factor 1 (IGF-1), which mediates many of HGH’s effects on tissues, muscles, and metabolism. As we age, the hypothalamus produces less GHRH, which means the pituitary gets fewer signals to release HGH, leading to declining IGF-1 levels and all the symptoms associated with growth hormone deficiency.
Sermorelin is a 29-amino acid peptide that mimics the first 29 amino acids of naturally occurring GHRH. When administered via subcutaneous injection, it binds to GHRH receptors in the pituitary gland and stimulates HGH secretion. Critically, this mechanism preserves the body’s own negative feedback loop, meaning HGH levels do not spike uncontrollably. The pituitary still self-regulates, which is one of the central safety advantages of Sermorelin over direct HGH injections.
This approach is sometimes described as “working with the body” rather than overriding it. Because Sermorelin relies on a functioning pituitary gland, it also helps preserve pituitary health over time, a benefit that synthetic HGH therapy does not offer.
Sermorelin therapy affects multiple systems in the body simultaneously, which is why patients often describe results that go well beyond a single symptom. Here is what the research and clinical experience suggest:
One of the most reported and measurable outcomes of Sermorelin therapy is a shift in body composition. Patients commonly experience an increase in lean muscle mass and a reduction in visceral fat, particularly around the abdomen. This happens because HGH stimulates lipolysis (the breakdown of fat) and supports protein synthesis in muscle tissue. For adults in Miami who are physically active but struggling with a body composition plateau, Sermorelin can be a meaningful catalyst.
Low HGH levels are often associated with chronic fatigue, reduced stamina, and diminished exercise capacity. As Sermorelin gradually elevates HGH and IGF-1 levels, many patients report significant improvements in daily energy, endurance and recovery time after workouts. Research suggests that Sermorelin treatment enhances muscle strength and endurance, making it a relevant option for adults in sports medicine or recovery-focused programs as well.
HGH is primarily released during slow-wave (deep) sleep. When HGH levels decline, this cycle becomes disrupted and poor sleep further suppresses HGH production, creating a feedback loop that accelerates aging. Sermorelin, administered before bedtime, aligns with the body’s natural nocturnal HGH secretion rhythms. Most patients report measurably better sleep quality within weeks of starting therapy. Improved sleep, in turn, benefits mood, cognitive function, immune health and metabolic regulation.
HGH plays a direct role in collagen synthesis and cellular regeneration. As levels rise with Sermorelin therapy, many patients notice improvements in skin elasticity, hydration and thickness. Hair quality and growth rates also tend to improve over time. While Sermorelin is not marketed as a cosmetic treatment, these effects are consistent with what we understand about HGH’s role in tissue repair and turnover.
Declining HGH levels are linked to reduced libido in both men and women. Sermorelin therapy has been shown to support improved sexual drive and function as part of a broader hormonal optimization effect. For patients managing sexual health concerns within our Men’s Health or Women’s Health programs at SFL Medical Group, Sermorelin may complement existing treatment strategies effectively.
Brain fog, difficulty concentrating, and mood fluctuations are common but underappreciated consequences of HGH deficiency in adults. Patients on Sermorelin therapy often report improved mental clarity, better focus and a more stable, elevated mood. These cognitive benefits are supported by the known role of IGF-1 in neuroplasticity and neuroprotection. If you are also experiencing anxiety, depression or difficulty concentrating, our Mental Health services at SFL Medical Group offer comprehensive evaluation and treatment.
The comparison between Sermorelin and direct HGH therapy is one of the most important conversations in hormone optimization today. Both approaches aim to address low growth hormone, but they differ significantly in mechanism, safety profile, cost and legal status.
| Factor | Sermorelin | Synthetic HGH |
|---|---|---|
| Mechanism | Stimulates the pituitary to produce natural HGH | Directly introduces exogenous HGH into the body |
| FDA Status | Compounded; no active FDA approval for adults | FDA-approved for specific medical diagnoses only |
| Safety Profile | Preserves pituitary feedback loop; lower risk of excess | Risk of supraphysiologic levels; suppresses natural production |
| Side Effects | Generally well-tolerated; injection site reactions most common | Water retention, joint pain, carpal tunnel, insulin resistance |
| Cost | Generally more affordable | Typically significantly more expensive |
| Long-term Pituitary Health | May support pituitary function over time | May suppress pituitary gland activity |
| Onset of Results | Gradual (4 to 8 weeks for initial improvements) | Faster, but with higher risk of adverse events |
Because Sermorelin increases endogenous HGH by stimulating the pituitary, it carries certain physiological and clinical advantages over direct HGH therapy. The body’s own regulatory mechanisms remain active, which means the risk of over-supplementation is significantly lower. Synthetic HGH, by contrast, bypasses this feedback loop entirely, potentially leading to supraphysiologic HGH levels, which are associated with complications including insulin resistance, fluid retention, and joint pain.
From a legal standpoint, synthetic HGH is a controlled substance approved by the U.S. Food and Drug Administration (FDA) only for specific medical diagnoses, including adult growth hormone deficiency confirmed by testing. Sermorelin, while compounded, operates in a different regulatory category and is more accessible as part of a supervised wellness program.
Synthetic HGH therapy can be prohibitively expensive, often running hundreds to thousands of dollars per month depending on dosage and formulation. Sermorelin therapy, delivered through compounding pharmacies, is generally more affordable and accessible, making it a practical choice for patients pursuing long-term hormone optimization without the financial burden of synthetic HGH.
Sermorelin is administered via subcutaneous injection, typically into the abdomen or thigh. Dosage is individualized based on a patient’s age, weight, HGH/IGF-1 lab values, and treatment goals.
Here is an overview of typical dosage protocols used in clinical practice:
All doses cited here are general reference ranges. Our physicians at SFL Medical Group personalize every Sermorelin protocol based on comprehensive lab work and clinical evaluation. Self-dosing without medical supervision is never recommended.
The most effective time to administer Sermorelin is 30 to 60 minutes before bedtime, on an empty stomach. This aligns with the body’s natural HGH secretion pattern, which peaks during the first phase of deep sleep. Patients typically follow a 5-nights-on, 2-nights-off weekly schedule, with periodic lab monitoring, usually at 6 to 12 week intervals to evaluate IGF-1 levels and adjust dosing accordingly.
Sermorelin is not a quick fix. Most patients begin noticing improvements in sleep quality and energy within the first 2 to 4 weeks. Noticeable changes in body composition and physical performance typically emerge after 8 to 12 weeks of consistent therapy. Full results, including skin improvements and sustained metabolic changes, often develop over 6 months or longer. Patience and consistency are essential.
Sermorelin therapy is appropriate for health-conscious adults who are experiencing symptoms of age-related HGH decline and who want a physiologically natural, supervised approach to hormone optimization. Ideal candidates typically include:
Sermorelin is not appropriate for individuals with active cancer or a history of certain tumor types, as growth hormone stimulation could be contraindicated. Our physicians conduct thorough screening before initiating any hormone therapy.
Women going through perimenopause and menopause often experience compounding hormonal shifts, declining estrogen and progesterone along with falling HGH and IGF-1 levels. Sermorelin has been shown to be safe and effective as an alternative or complement to hormone therapy in this population. Women commonly report improvements in body composition, libido, energy and skin quality. For women exploring hormone optimization, our Women’s Health services at SFL Medical Group provide a comprehensive evaluation framework.
Men in their 30s, 40s and beyond frequently experience what is sometimes called andropause, a gradual decline in testosterone and HGH simultaneously. Sermorelin addresses the HGH side of this equation directly. Many men report improved energy, stronger workouts, reduced belly fat, and better mood regulation on Sermorelin therapy. When combined with other therapies in our Men’s Health program, results can be transformative.
Sermorelin is often discussed alongside Hormone Replacement Therapy (HRT), and for good reason, they address related but distinct aspects of adult hormonal health. While HRT typically focuses on sex hormones (estrogen, progesterone, testosterone), Sermorelin targets the growth hormone axis. Many patients benefit from both approaches, especially when hormonal decline is multifactorial.
At SFL Medical Group, we evaluate each patient’s full hormonal picture before recommending a protocol. Combining Sermorelin with appropriately managed Hormone Replacement Therapy (HRT) can address fatigue, metabolic dysfunction, sexual health and aging from multiple angles. Our HRT blog post provides a deeper dive into how these therapies can work together.
Sermorelin is generally well-tolerated when administered under medical supervision. The most commonly reported side effects are mild and localized:
Because Sermorelin preserves the pituitary’s self-regulatory function, the risk of excessive HGH levels is substantially lower than with direct HGH therapy. Long-term safety data on Sermorelin in adults remains limited, which underscores the importance of medical supervision, regular lab monitoring, and an evidence-based treatment protocol.
Patients with a history of certain cancers, active neoplastic disease, or hypersensitivity to Sermorelin components should not use this therapy. A thorough consultation and baseline labs are essential first steps. Our team also offers a full range of Rheumatology services for patients managing inflammatory or autoimmune conditions alongside hormonal therapy.
Miami is home to no shortage of wellness clinics, but not all hormone therapy programs are equal. At South Florida Multispecialty Medical Group, Sermorelin therapy is delivered within a full-spectrum clinical framework, not as a standalone product from a med spa, but as part of a medically supervised, multispecialty care model.
Our team conducts comprehensive baseline evaluations including IGF-1, HGH, metabolic panels, and full hormone profiles before initiating therapy. Every Sermorelin protocol is individualized, monitored and adjusted based on clinical response and lab data. Our patients receive ongoing support from a multidisciplinary team that includes specialists in Men’s Health, Women’s Health, Rheumatology, Vascular Surgery and more.
We believe hormone optimization is not a shortcut, it’s a science. And when done right, Sermorelin therapy can be a powerful part of a long-term strategy for energy, vitality and healthy aging. If you are ready to find out whether Sermorelin is right for you, we invite you to schedule a consultation at SFL Medical Group in Miami.
Dr. Peter Hanna is a board-certified podiatrist and reconstructive foot & ankle surgeon with over 15 years of experience. He serves as Director of Podiatry at South Florida Multispecialty Medical Group, specializing in complex reconstruction, minimally invasive surgery, and diabetic foot care.
Trust & Transparency: Editorial Policy | Contact Us
More To Explore
Most people pick up a pair of shoes based on what looks good or what is on sale and wear them for everything. Walking
Millions of men silently accept fatigue, lost libido, and emotional flatness as “just getting older” when in reality, a treatable hormonal shift called andropause
©2026 South Florida Multispecialty Medical Group. All Rights Reserved.